Health
World’s First Phase III Clinical Trial of COVID-19 Inactivated Vaccine Begins in UAE – Up News Info
Article content continued It follows successful phase I and II trials by Sinopharm in China, resulting in 100% of volunteers generating antibodies. G42 Healthcare CEO Ashish Koshy said: “We are enormously proud to partner with Sinopharm CNBG in this groundbre…
It follows successful phase I and II trials by Sinopharm in China, resulting in 100% of volunteers generating antibodies.
G42 Healthcare CEO Ashish Koshy said: We are enormously proud to partner with Sinopharm CNBG in this groundbreaking phase III clinical trial. Using our AI solutions, super-computer, advanced diagnostics solutions for COVID-19, and G42 Healthcare will be responsible for running clinical operations for these trials.
Jingjin Zhu, President, Biological products, Sinopharm CNBG …
-
Noosa News24 hours agoFarmers angry as Woolworths imports US butter in green and gold packaging
-
General20 hours agoLiberal politicians on Qantas plane that made urgent turnaround to Adelaide
-
General9 hours agoAllegations against ex-Attorney-General Mark Dreyfus removed from Linda Reynolds action against Commonwealth
-
Noosa News9 hours agoToombul Shopping Centre site thrown lifeline after Mirvac announces sale with ‘priority’ to build new retail centre